tiprankstipranks
Regeneron (REGN)
NASDAQ:REGN
US Market
REGN
Regeneron
RESEARCH TOOLSreports

Regeneron (REGN) Stock Forecast & Price Target

5,164 Followers
See the Price Targets and Ratings of:

REGN Analyst Ratings

Strong Buy
24Ratings
Strong Buy
19 Buy
5 Hold
0 Sell
Based on 24 analysts giving stock ratings to
Regeneron
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

REGN Stock 12 Month Forecast

Average Price Target

$871.09
▲(12.74% Upside)
Based on 24 Wall Street analysts offering 12 month price targets for Regeneron in the last 3 months. The average price target is $871.09 with a high forecast of $1,057.00 and a low forecast of $742.00. The average price target represents a 12.74% change from the last price of $772.64.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"487":"$487","1058":"$1,058","629.75":"$629.8","772.5":"$772.5","915.25":"$915.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1057,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.06K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":871.086956521739,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$871.09</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":742,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$742.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[487,629.75,772.5,915.25,1058],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,777.25,798.7692307692307,820.2884615384615,841.8076923076923,863.3269230769231,884.8461538461538,906.3653846153846,927.8846153846154,949.4038461538462,970.9230769230769,992.4423076923077,1013.9615384615385,1035.4807692307693,{"y":1057,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,777.25,784.4682274247491,791.6864548494983,798.9046822742474,806.1229096989966,813.3411371237457,820.559364548495,827.7775919732441,834.9958193979933,842.2140468227424,849.4322742474916,856.6505016722407,863.8687290969899,{"y":871.086956521739,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,777.25,774.5384615384615,771.8269230769231,769.1153846153846,766.4038461538462,763.6923076923077,760.9807692307693,758.2692307692307,755.5576923076923,752.8461538461538,750.1346153846154,747.4230769230769,744.7115384615385,{"y":742,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":613.647,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 46,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":586.793,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 48,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":488.864,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 62,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":532.789,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 46,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":556.654,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 56,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":579.276,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 47,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":598.468,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 58,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":650.201,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 46,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":749.208,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 46,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":770.942,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":754.112,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 42,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":790.81,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":777.25,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$1,057Average Price Target$871.09Lowest Price Target$742.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on REGN
Mohit Bansal
Wells Fargo
Wells Fargo
$825
Hold
6.78%
Upside
Assigned
04/02/26
Wells Fargo Sticks to Its Hold Rating for Regeneron (REGN)
Truist Financial Analyst forecast on REGN
Gregory Renza
Truist Financial
Truist Financial
$818→$801
Buy
3.67%
Upside
Reiterated
03/31/26
Truist Financial Sticks to Their Buy Rating for Regeneron (REGN)
Piper Sandler Analyst forecast on REGN
Biren Amin
Piper Sandler
Piper Sandler
$875
Buy
13.25%
Upside
Reiterated
03/31/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Goldman Sachs Analyst forecast on REGN
Salveen Richter
Goldman Sachs
Goldman Sachs
$914→$967
Buy
25.16%
Upside
Assigned
03/20/26
Regeneron (REGN) Receives a Buy from Goldman Sachs
Bank of America Securities Analyst forecast on REGN
Tazeen Ahmad
Bank of America Securities
Bank of America Securities
$860
Buy
11.31%
Upside
Reiterated
03/20/26
Analysts Offer Insights on Healthcare Companies: Electrocore (NASDAQ: ECOR) and Regeneron (NASDAQ: REGN)
Jefferies Analyst forecast on REGN
Akash Tewari
Jefferies
Jefferies
$885→$890
Buy
15.19%
Upside
Reiterated
03/11/26
Scotiabank Analyst forecast on REGN
Louise Chen
Scotiabank
Scotiabank
$770
Hold
-0.34%
Downside
Reiterated
03/10/26
Scotiabank Sticks to Their Hold Rating for Regeneron (REGN)
Morgan Stanley Analyst forecast on REGN
Terence Flynn
Morgan Stanley
Morgan Stanley
$769
Hold
-0.47%
Downside
Reiterated
03/08/26
Analysts Offer Insights on Healthcare Companies: Exelixis (NASDAQ: EXEL), Hims & Hers Health (NYSE: HIMS) and Regeneron (NASDAQ: REGN)
Barclays Analyst forecast on REGN
Eliana Merle
Barclays
Barclays
$787.5→$923
Buy
19.46%
Upside
Initiated
03/05/26
Regeneron initiated with an Overweight at BarclaysRegeneron initiated with an Overweight at Barclays
RBC Capital Analyst forecast on REGN
Brian Abrahams
RBC Capital
RBC Capital
$745→$765
Hold
-0.99%
Downside
Reiterated
03/02/26
Regeneron (REGN) Receives a Hold from RBC Capital
Citi Analyst forecast on REGN
Geoff Meacham
Citi
Citi
$900
Buy
16.48%
Upside
Reiterated
02/25/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Canaccord Genuity Analyst forecast on REGN
John Newman
Canaccord Genuity
Canaccord Genuity
$1,057
Buy
36.80%
Upside
Reiterated
02/23/26
Canaccord Genuity Remains a Buy on Regeneron (REGN)
Guggenheim Analyst forecast on REGN
Yatin Suneja
Guggenheim
Guggenheim
$865→$975
Buy
26.19%
Upside
Reiterated
02/08/26
Regeneron price target raised to $975 from $865 at GuggenheimRegeneron price target raised to $975 from $865 at Guggenheim
Evercore ISI Analyst forecast on REGN
Cory Kasimov
Evercore ISI
Evercore ISI
$875
Buy
13.25%
Upside
Reiterated
02/02/26
Evercore ISI Keeps Their Buy Rating on Regeneron (REGN)
J.P. Morgan Analyst forecast on REGN
Chris Schott
J.P. Morgan
J.P. Morgan
$850→$950
Buy
22.96%
Upside
Reiterated
02/02/26
Regeneron price target raised to $950 from $850 at JPMorganRegeneron price target raised to $950 from $850 at JPMorgan
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on REGN
Mohit Bansal
Wells Fargo
Wells Fargo
$825
Hold
6.78%
Upside
Assigned
04/02/26
Wells Fargo Sticks to Its Hold Rating for Regeneron (REGN)
Truist Financial Analyst forecast on REGN
Gregory Renza
Truist Financial
Truist Financial
$818→$801
Buy
3.67%
Upside
Reiterated
03/31/26
Truist Financial Sticks to Their Buy Rating for Regeneron (REGN)
Piper Sandler Analyst forecast on REGN
Biren Amin
Piper Sandler
Piper Sandler
$875
Buy
13.25%
Upside
Reiterated
03/31/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Goldman Sachs Analyst forecast on REGN
Salveen Richter
Goldman Sachs
Goldman Sachs
$914→$967
Buy
25.16%
Upside
Assigned
03/20/26
Regeneron (REGN) Receives a Buy from Goldman Sachs
Bank of America Securities Analyst forecast on REGN
Tazeen Ahmad
Bank of America Securities
Bank of America Securities
$860
Buy
11.31%
Upside
Reiterated
03/20/26
Analysts Offer Insights on Healthcare Companies: Electrocore (NASDAQ: ECOR) and Regeneron (NASDAQ: REGN)
Jefferies Analyst forecast on REGN
Akash Tewari
Jefferies
Jefferies
$885→$890
Buy
15.19%
Upside
Reiterated
03/11/26
Scotiabank Analyst forecast on REGN
Louise Chen
Scotiabank
Scotiabank
$770
Hold
-0.34%
Downside
Reiterated
03/10/26
Scotiabank Sticks to Their Hold Rating for Regeneron (REGN)
Morgan Stanley Analyst forecast on REGN
Terence Flynn
Morgan Stanley
Morgan Stanley
$769
Hold
-0.47%
Downside
Reiterated
03/08/26
Analysts Offer Insights on Healthcare Companies: Exelixis (NASDAQ: EXEL), Hims & Hers Health (NYSE: HIMS) and Regeneron (NASDAQ: REGN)
Barclays Analyst forecast on REGN
Eliana Merle
Barclays
Barclays
$787.5→$923
Buy
19.46%
Upside
Initiated
03/05/26
Regeneron initiated with an Overweight at BarclaysRegeneron initiated with an Overweight at Barclays
RBC Capital Analyst forecast on REGN
Brian Abrahams
RBC Capital
RBC Capital
$745→$765
Hold
-0.99%
Downside
Reiterated
03/02/26
Regeneron (REGN) Receives a Hold from RBC Capital
Citi Analyst forecast on REGN
Geoff Meacham
Citi
Citi
$900
Buy
16.48%
Upside
Reiterated
02/25/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Canaccord Genuity Analyst forecast on REGN
John Newman
Canaccord Genuity
Canaccord Genuity
$1,057
Buy
36.80%
Upside
Reiterated
02/23/26
Canaccord Genuity Remains a Buy on Regeneron (REGN)
Guggenheim Analyst forecast on REGN
Yatin Suneja
Guggenheim
Guggenheim
$865→$975
Buy
26.19%
Upside
Reiterated
02/08/26
Regeneron price target raised to $975 from $865 at GuggenheimRegeneron price target raised to $975 from $865 at Guggenheim
Evercore ISI Analyst forecast on REGN
Cory Kasimov
Evercore ISI
Evercore ISI
$875
Buy
13.25%
Upside
Reiterated
02/02/26
Evercore ISI Keeps Their Buy Rating on Regeneron (REGN)
J.P. Morgan Analyst forecast on REGN
Chris Schott
J.P. Morgan
J.P. Morgan
$850→$950
Buy
22.96%
Upside
Reiterated
02/02/26
Regeneron price target raised to $950 from $850 at JPMorganRegeneron price target raised to $950 from $850 at JPMorgan
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Regeneron

3 Months
xxx
Success Rate
9/15 ratings generated profit
60%
Average Return
+4.19%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +4.19% per trade.
1 Year
Evan SeigermanBMO Capital
Success Rate
34/44 ratings generated profit
77%
Average Return
+12.32%
Copying Evan Seigerman's trades and holding each position for 1 Year would result in 77.27% of your transactions generating a profit, with an average return of +12.32% per trade.
2 Years
xxx
Success Rate
20/26 ratings generated profit
77%
Average Return
+19.23%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 76.92% of your transactions generating a profit, with an average return of +19.23% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

REGN Analyst Recommendation Trends

Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
1
0
0
0
0
Buy
45
41
42
41
21
Hold
16
16
16
15
10
Sell
2
0
0
0
0
Strong Sell
0
0
0
0
0
total
64
57
58
56
31
In the current month, REGN has received 21 Buy Ratings, 10 Hold Ratings, and 0 Sell Ratings. REGN average Analyst price target in the past 3 months is 871.09.
Each month's total comprises the sum of three months' worth of ratings.

REGN Financial Forecast

REGN Earnings Forecast

Next quarter’s earnings estimate for REGN is $9.09 with a range of $5.77 to $12.75. The previous quarter’s EPS was $11.44. REGN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year REGN has Performed in-line its overall industry.
Next quarter’s earnings estimate for REGN is $9.09 with a range of $5.77 to $12.75. The previous quarter’s EPS was $11.44. REGN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year REGN has Performed in-line its overall industry.

REGN Sales Forecast

Next quarter’s sales forecast for REGN is $3.46B with a range of $3.06B to $3.92B. The previous quarter’s sales results were $3.88B. REGN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year REGN has Performed in-line its overall industry.
Next quarter’s sales forecast for REGN is $3.46B with a range of $3.06B to $3.92B. The previous quarter’s sales results were $3.88B. REGN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year REGN has Performed in-line its overall industry.

REGN Stock Forecast FAQ

What is REGN’s average 12-month price target, according to analysts?
Based on analyst ratings, Regeneron’s 12-month average price target is 871.09.
    What is REGN’s upside potential, based on the analysts’ average price target?
    Regeneron has 12.74% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is REGN a Buy, Sell or Hold?
          Regeneron has a consensus rating of Strong Buy which is based on 19 buy ratings, 5 hold ratings and 0 sell ratings.
            What is Regeneron’s price target?
            The average price target for Regeneron is 871.09. This is based on 24 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $1,057.00 ,the lowest forecast is $742.00. The average price target represents 12.74% Increase from the current price of $772.64.
              What do analysts say about Regeneron?
              Regeneron’s analyst rating consensus is a Strong Buy. This is based on the ratings of 24 Wall Streets Analysts.
                How can I buy shares of REGN?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.